Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 398 articles:
HTML format



Single Articles


    July 2024
  1. BIEGUS J, Mebazaa A, Davison B, Cotter G, et al
    Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.
    J Am Coll Cardiol. 2024;84:323-336.
    PubMed     Abstract available


  2. LOPEZ J, Liu Y, Butler J, Del Prato S, et al
    Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
    J Am Coll Cardiol. 2024;84:233-243.
    PubMed     Abstract available


  3. HAHN RT, Lindenfeld J, Bohm M, Edelmann F, et al
    Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:195-212.
    PubMed     Abstract available


  4. PETRIE MC, Borlaug BA, Butler J, Davies MJ, et al
    Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
    J Am Coll Cardiol. 2024;84:27-40.
    PubMed     Abstract available


  5. VAN KIMMENADE RRJ, Hassing C
    STEP-HFpEF: A Large Step for HFpEF.
    J Am Coll Cardiol. 2024;84:41-42.
    PubMed    


    June 2024
  6. CHEEMA B, Chokshi A, Orimoloye O, Ardehali H, et al
    Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:2674-2689.
    PubMed     Abstract available


  7. VERMA S, Butler J, Borlaug BA, Davies M, et al
    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials.
    J Am Coll Cardiol. 2024 Jun 19:S0735-1097(24)07445.
    PubMed     Abstract available


  8. SCHOU M, Petrie MC, Borlaug BA, Butler J, et al
    Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program.
    J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07126.
    PubMed     Abstract available


  9. LALA A, Mentz RJ, Santos-Gallego CG
    The Quest for Understanding Diabetic Cardiomyopathy: Can We Preserve Function and Prevent Failure?
    J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07407.
    PubMed    


  10. MESSORI A, Romeo MR, Trippoli S
    Remote Monitoring in Heart Failure: Inclusion of Different Studies in the Same Meta-Analysis.
    J Am Coll Cardiol. 2024;83:e231.
    PubMed    


  11. KOCHAR A, Gattani R, Vaduganathan M
    Patient Selection Is the Key to EMPACTing Development of Heart Failure After Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:2247-2249.
    PubMed    


  12. CANNATA A, Bromage DI, Piper SE, McDonagh TA, et al
    Heart Failure With Preserved Ejection Fraction: Prioritizing Patients' Symptoms.
    J Am Coll Cardiol. 2024 Jun 11:S0735-1097(24)07300.
    PubMed    


    May 2024
  13. KONDO T, Mogensen UM, Talebi A, Gasparyan SB, et al
    Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.
    J Am Coll Cardiol. 2024;83:1973-1986.
    PubMed     Abstract available


  14. OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al
    Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
    J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204.
    PubMed    


  15. FERRO CJ, Townend JN
    Mineralocorticoid Receptor Antagonism in Heart Failure and Chronic Kidney Disease: Short-Term Pain for Long-Term Gain.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06944.
    PubMed    


  16. MATSUMOTO S, Henderson AD, Shen L, Yang M, et al
    Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)06945.
    PubMed     Abstract available


    April 2024
  17. KITTIPIBUL V, Cox ZL, Chesdachai S, Fiuzat M, et al
    Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1568-1578.
    PubMed     Abstract available


  18. BURCHILL LJ, Jain CC, Miranda WR
    Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
    J Am Coll Cardiol. 2024;83:1415-1417.
    PubMed    


  19. MARTON A, Saffari SE, Rauh M, Sun RN, et al
    Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
    J Am Coll Cardiol. 2024;83:1386-1398.
    PubMed     Abstract available


  20. NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al
    Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease.
    J Am Coll Cardiol. 2024;83:1403-1414.
    PubMed     Abstract available


  21. ACHANTA A, Belak L, Ritchie CS, Januzzi JL, et al
    Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2024;83:1348-1350.
    PubMed    


  22. COSTANZO MR, Januzzi JL
    Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
    J Am Coll Cardiol. 2024;83:1307-1309.
    PubMed    


  23. COX ZL, Collins SP, Hernandez GA, McRae AT 3rd, et al
    Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2024;83:1295-1306.
    PubMed     Abstract available


  24. COTTER G, Davison B, Chioncel O
    Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1243-1252.
    PubMed     Abstract available


  25. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
    Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
    PubMed     Abstract available


  26. CHATUR S, Neuen BL, Claggett BL, Beldhuis IE, et al
    Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06691.
    PubMed     Abstract available


  27. MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
    Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
    PubMed    


    March 2024
  28. ATALLAH B, Ghalib HH
    Pooling the NT-proBNP Benefits of ARNI: Fret the Index Hospitalization No More.
    J Am Coll Cardiol. 2024;83:1133-1135.
    PubMed    


  29. MORROW DA, Velazquez EJ, Desai AS, DeVore AD, et al
    Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
    J Am Coll Cardiol. 2024;83:1123-1132.
    PubMed     Abstract available


  30. GONZALEZ-LOPEZ E, McPhail ED, Salas-Anton C, Dominguez F, et al
    Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1085-1099.
    PubMed     Abstract available


  31. FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al
    Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478.
    PubMed     Abstract available


  32. FUSTER V
    Editor-in-Chief's Top Picks From 2023.
    J Am Coll Cardiol. 2024;83:961-1026.
    PubMed     Abstract available


  33. HAGE C, Sundstrom J, Lund LH
    More evidence that heart failure with normal EF distinct from heart failure is below normal EF.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990.
    PubMed    


  34. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
    Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:932-950.
    PubMed     Abstract available


  35. UDELL JA, Armstrong DWJ
    Targeting the Natriuretic Peptide System to Improve Outcomes: PARADISE Lost or Found.
    J Am Coll Cardiol. 2024;83:915-917.
    PubMed    


  36. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
    Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
    J Am Coll Cardiol. 2024;83:904-914.
    PubMed     Abstract available


  37. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2024 Mar 2:S0735-1097(23)08354.
    PubMed    


    February 2024
  38. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    PubMed     Abstract available


  39. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    PubMed     Abstract available


  40. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    PubMed     Abstract available


  41. FUDIM M, Butler J, Kittipibul V
    Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure.
    J Am Coll Cardiol. 2024;83:695-698.
    PubMed    


  42. LINDENFELD J, Costanzo MR, Zile MR, Ducharme A, et al
    Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024;83:682-694.
    PubMed     Abstract available


  43. SCHUMACHER KR, Vitale C
    It Is Shocking How Little We Have Talked About Cardiogenic Shock in Pediatrics.
    J Am Coll Cardiol. 2024;83:609-610.
    PubMed    


  44. PURI K, Jentzer JC, Spinner JA, Hope KD, et al
    Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in Children.
    J Am Coll Cardiol. 2024;83:595-608.
    PubMed     Abstract available


    January 2024
  45. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    PubMed     Abstract available


  46. TROLLE LAGERROS Y, Grotta A, Freyland S, Grannas D, et al
    Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.
    J Am Coll Cardiol. 2024;83:417-426.
    PubMed     Abstract available


  47. PACKER M
    Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:371-381.
    PubMed     Abstract available


  48. ALOGNA A, Berboth L, Faragli A, Otvos J, et al
    Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.
    J Am Coll Cardiol. 2024;83:47-59.
    PubMed     Abstract available


    December 2023
  49. LAMBERT G, Chemello K, Gallo A
    Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis.
    J Am Coll Cardiol. 2023;82:2292-2295.
    PubMed    


    November 2023
  50. VADUGANATHAN M, Ostrominski JW
    Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the Ejection Fraction Divide.
    J Am Coll Cardiol. 2023;82:2097-2100.
    PubMed    


  51. BUTLER J, Abildstrom SZ, Borlaug BA, Davies MJ, et al
    Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;82:2087-2096.
    PubMed     Abstract available


  52. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
    Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2023;82:1989-2005.
    PubMed     Abstract available


  53. BURGER PM, Visseren FLJ, Dorresteijn JAN
    Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e193.
    PubMed    


  54. MORZE J, Rynkiewicz A
    C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e191-e192.
    PubMed    


  55. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    PubMed     Abstract available


  56. OUWERKERK W, Belo Pereira JP, Maasland T, Emmens JE, et al
    Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
    J Am Coll Cardiol. 2023;82:1921-1931.
    PubMed     Abstract available


  57. COCA SG
    SGLT2i and Deterioration of Kidney Function in Heart Failure: Another Demonstration for Tolerance of "Hypercreatininemia".
    J Am Coll Cardiol. 2023;82:1864-1867.
    PubMed    


  58. AGGARWAL R, Bhatt DL, Szarek M, Cannon CP, et al
    Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c.
    J Am Coll Cardiol. 2023;82:1842-1851.
    PubMed     Abstract available


    October 2023
  59. REIL JC, Eitel I, Stiermaier T
    Reply: Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e145.
    PubMed    


  60. KOMAMURA K
    Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e143.
    PubMed    


  61. HONG KN, Eshraghian EA, Arad M, Argiro A, et al
    International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1628-1647.
    PubMed     Abstract available


  62. ARNOLD SV, Goates S, Sorajja P, Adams DH, et al
    Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07743.
    PubMed     Abstract available


  63. OHSHIRO Y
    Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;82:e133.
    PubMed    


  64. TEDFORD RJ, Leacche M, Lorts A, Drakos SG, et al
    Durable Mechanical Circulatory Support: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;82:1464-1481.
    PubMed     Abstract available


  65. GREGSON J, Stone GW, Bhatt DL, Packer M, et al
    Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1445-1463.
    PubMed     Abstract available


    September 2023
  66. VERBRUGGE FH, Martens P, Mullens W
    Reply: Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e113.
    PubMed    


  67. PAI RG
    Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e111.
    PubMed    


  68. GOEL K, Lindenfeld J, Makkar R, Naik H, et al
    Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    J Am Coll Cardiol. 2023;82:1281-1297.
    PubMed     Abstract available


    August 2023
  69. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    PubMed     Abstract available


  70. CHATUR S, Vaduganathan M, Claggett BL, Mc Causland FR, et al
    Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m(2).
    J Am Coll Cardiol. 2023 Aug 23:S0735-1097(23)06532.
    PubMed     Abstract available


  71. CHRISPIN J, Merchant FM, Lakdawala NK, Wu KC, et al
    Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:735-747.
    PubMed     Abstract available


  72. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
    J Am Coll Cardiol. 2023;82:559-571.
    PubMed     Abstract available


  73. JALLOH MB, Averbuch T, Kulkarni P, Granger CB, et al
    Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3.
    J Am Coll Cardiol. 2023;82:544-558.
    PubMed     Abstract available


  74. PATOLIA H, Khan MS, Fonarow GC, Butler J, et al
    Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3.
    J Am Coll Cardiol. 2023;82:529-543.
    PubMed     Abstract available


  75. GRAPSA J, Pinney SP
    Right Heart Dysfunction in HFpEF: More Complex and More Common Than We Thought.
    J Am Coll Cardiol. 2023;82:500-502.
    PubMed    


  76. BUTLER J, Khan MS, Fonarow GC
    The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05963.
    PubMed    


  77. KONDO T, Wang X, Yang M, Jhund PS, et al
    Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05964.
    PubMed     Abstract available


  78. SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al
    First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With Advanced Heart Failure Undergoing VT Ablation.
    J Am Coll Cardiol. 2023;82:469-471.
    PubMed    


  79. DEVORE AD, Allen LA
    A Global Challenge and a Global Opportunity for the Heart Failure Community.
    J Am Coll Cardiol. 2023;82:445-447.
    PubMed    


  80. FOROUTAN F, Rayner DG, Ross HJ, Ehler T, et al
    Global Comparison of Readmission Rates for Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:430-444.
    PubMed     Abstract available


  81. JIALAL I, Ebong IA
    The Evolving Role of C-Reactive Protein in Heart Failure: Implications for Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:427-429.
    PubMed    


  82. BURGER PM, Koudstaal S, Mosterd A, Fiolet ATL, et al
    C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:414-426.
    PubMed     Abstract available


  83. SAUER AJ, Hsia J
    Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With Reduced Ejection Fraction: Better Late Than Never?
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06074.
    PubMed    


  84. MATSUMOTO S, Kondo T, Jhund PS, Campbell RT, et al
    Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06073.
    PubMed     Abstract available


    July 2023
  85. VIJAYARAMAN P, Sharma PS, Cano O, Ponnusamy SS, et al
    Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy.
    J Am Coll Cardiol. 2023;82:228-241.
    PubMed     Abstract available


  86. DOCHERTY KF, McDowell K, Welsh P, Osmanska J, et al
    Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:142-157.
    PubMed     Abstract available


  87. ANKER MS, von Haehling S, Landmesser U
    Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.
    J Am Coll Cardiol. 2023;82:139-141.
    PubMed    


  88. BAYES-GENIS A, de la Espriella R, Nunez J
    CA125 for Fluid Overload Monitoring: A New Life for an Old Tool.
    J Am Coll Cardiol. 2023;82:158-160.
    PubMed    


  89. GRINSTEIN J, Belkin MN, Kalantari S, Bourque K, et al
    Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:70-81.
    PubMed     Abstract available


    June 2023
  90. WIVIOTT SD, Berg DD
    SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death: Clarity and Consistency.
    J Am Coll Cardiol. 2023;81:2388-2390.
    PubMed    


  91. USMAN MS, Siddiqi TJ, Anker SD, Bakris GL, et al
    Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
    J Am Coll Cardiol. 2023;81:2377-2387.
    PubMed     Abstract available


  92. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;81:2299-2311.
    PubMed     Abstract available


  93. STEVENSON LW, Ross HJ, Rathman LD, Boehmer JP, et al
    Remote Monitoring for Heart Failure Management at Home.
    J Am Coll Cardiol. 2023;81:2272-2291.
    PubMed     Abstract available


  94. GOLDBERG LR
    Disrupting the Definition of Heart Failure: A Rose by Any Other Name.
    J Am Coll Cardiol. 2023;81:2243-2245.
    PubMed    


  95. MOHEBI R, Wang D, Lau ES, Parekh JK, et al
    Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort.
    J Am Coll Cardiol. 2023;81:2231-2242.
    PubMed     Abstract available


  96. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    PubMed     Abstract available


  97. FONAROW GC, Greene SJ
    Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum.
    J Am Coll Cardiol. 2023;81:2145-2148.
    PubMed    


  98. PAGNESI M, Metra M, Cohen-Solal A, Edwards C, et al
    Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2023;81:2131-2144.
    PubMed     Abstract available


    May 2023
  99. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    PubMed     Abstract available


  100. SCOTTI A, Coisne A, Granada JF, Driggin E, et al
    Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2023 May 27:S0735-1097(23)05584.
    PubMed     Abstract available


  101. SUKUMAR S, Wasfy JH, Januzzi JL, Peppercorn J, et al
    Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2043-2055.
    PubMed     Abstract available


  102. VERBRUGGE FH, Martens P, Dauw J, Nijst P, et al
    Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2023;81:2013-2024.
    PubMed     Abstract available


  103. JOYCE E
    Natriuretic Response as a Biomarker of Decongestion in ADHF: Beyond Going With the Flow.
    J Am Coll Cardiol. 2023;81:2025-2027.
    PubMed    


  104. KRISTENSEN SL, Jensen J, Schou M
    SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
    J Am Coll Cardiol. 2023;81:1915-1917.
    PubMed    


  105. BUTLER J, Packer M, Siddiqi TJ, Bohm M, et al
    Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;81:1902-1914.
    PubMed     Abstract available


  106. INCIARDI RM, Abanda M, Shah A, Cikes M, et al
    Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Trial.
    J Am Coll Cardiol. 2023 May 15:S0735-1097(23)05587.
    PubMed     Abstract available


  107. MENTZ RJ, Ward JH, Hernandez AF, Lepage S, et al
    Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure.
    J Am Coll Cardiol. 2023 May 11:S0735-1097(23)05429.
    PubMed     Abstract available


  108. KITTLESON MM, Panjrath GS, Amancherla K, Davis LL, et al
    2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2023;81:1835-1878.
    PubMed    


  109. BORLAUG BA, Sharma K, Shah SJ, Ho JE, et al
    Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;81:1810-1834.
    PubMed     Abstract available


  110. KODALI SK, Hahn RT, Davidson CJ, Narang A, et al
    1-Year Outcomes of Transcatheter Tricuspid Valve Repair.
    J Am Coll Cardiol. 2023;81:1766-1776.
    PubMed     Abstract available


  111. VENTURA HO, Lavie CJ, Mehra MR
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: You Win Some, You Lose Some.
    J Am Coll Cardiol. 2023 May 3:S0735-1097(23)05526.
    PubMed    


  112. MAMIC P, Snyder M, Tang WHW
    Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1729-1739.
    PubMed     Abstract available


  113. FONAROW GC, Van Spall HGC, Januzzi JL Jr
    Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure.
    J Am Coll Cardiol. 2023;81:1694-1696.
    PubMed    


    April 2023
  114. MIRANDA WR, Jain CC, Borlaug BA, Jaffe AS, et al
    Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan.
    J Am Coll Cardiol. 2023;81:1590-1600.
    PubMed     Abstract available


  115. LENA A, Wilkenshoff U, Hadzibegovic S, Porthun J, et al
    Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
    J Am Coll Cardiol. 2023;81:1569-1586.
    PubMed     Abstract available


  116. VERMA S, Bhatt DL, Dhingra NK, Steg PG, et al
    Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure.
    J Am Coll Cardiol. 2023;81:1546-1549.
    PubMed    


  117. KHAN H, Kunutsor SK
    Nonsteroidal Anti-Inflammatory Drugs and Type 2 Diabetes: A Recipe for Heart Failure?
    J Am Coll Cardiol. 2023;81:1471-1473.
    PubMed    


  118. HOLT A, Strange JE, Nouhravesh N, Nielsen SK, et al
    Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2023;81:1459-1470.
    PubMed     Abstract available


  119. COCA SG
    Learning to Embrace the Decline in eGFR After Initiation of Therapies for Heart Failure.
    J Am Coll Cardiol. 2023;81:1456-1458.
    PubMed    


  120. AHMAD T, Desai NR, Clark KAA
    The EHR Has Exposed an Urgent Moral Imperative to Improve Heart Failure Care.
    J Am Coll Cardiol. 2023;81:1317-1319.
    PubMed    


  121. YUN M, Bai Y, Nie B, Zhang X, et al
    Reply: Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
    J Am Coll Cardiol. 2023;81:e111.
    PubMed    


  122. VALENZA G
    Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
    J Am Coll Cardiol. 2023;81:e109.
    PubMed    


  123. CARNICELLI AP, Agarwal R, Tedford RJ, Ramaiah V, et al
    Critical Care Enrichment During Advanced Heart Failure Training.
    J Am Coll Cardiol. 2023;81:1296-1299.
    PubMed    


  124. SORAJJA P, Cavalcante JL, Rodes-Cabau J
    Upstream Relief of Heart Failure Via Aortic Valve Replacement.
    J Am Coll Cardiol. 2023;81:1245-1247.
    PubMed    


  125. KHAN KR, Khan OA, Chen C, Liu Y, et al
    Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:1235-1244.
    PubMed     Abstract available


    March 2023
  126. DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al
    Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.
    J Am Coll Cardiol. 2023;81:1151-1161.
    PubMed     Abstract available


  127. LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al
    Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:1035-1045.
    PubMed     Abstract available


  128. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
    Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
    J Am Coll Cardiol. 2023;81:964-975.
    PubMed     Abstract available


  129. VADUGANATHAN M, Claggett BL, Jhund P, Miao ZM, et al
    Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;81:1004-1006.
    PubMed    


  130. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
    Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2023 Mar 14:S0735-1097(23)00368.
    PubMed     Abstract available


  131. LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al
    Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e69.
    PubMed    


  132. WU J, Liang J, Huang Y
    Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e67.
    PubMed    


  133. MENASCHE P
    Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
    J Am Coll Cardiol. 2023;81:864-866.
    PubMed    


  134. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
    Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:849-863.
    PubMed     Abstract available


    February 2023
  135. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
    Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:708-710.
    PubMed    


  136. BHATT AS, Varshney AS, Moscone A, Claggett BL, et al
    Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.
    J Am Coll Cardiol. 2023 Feb 21:S0735-1097(23)04471.
    PubMed     Abstract available


  137. CHATUR S, Claggett BL, McCausland FR, Rouleau J, et al
    Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.
    J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00335.
    PubMed     Abstract available


  138. MUKHOPADHYAY A, Reynolds HR, Phillips LM, Nagler AR, et al
    Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
    J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00329.
    PubMed     Abstract available


  139. WEINTRAUB WS
    Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;81:474-476.
    PubMed    


  140. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
    Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:460-473.
    PubMed     Abstract available


    January 2023
  141. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:413-424.
    PubMed     Abstract available


  142. PAGE RL 2ND
    The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation.
    J Am Coll Cardiol. 2023;81:332-335.
    PubMed    


  143. KHAN MS, Shahid I, Anker SD, Fonarow GC, et al
    Albuminuria and Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:270-282.
    PubMed     Abstract available


  144. MENTIAS A, Smedira NG, Krishnaswamy A, Reed GW, et al
    Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:105-115.
    PubMed     Abstract available


  145. MARON MS, Masri A, Choudhury L, Olivotto I, et al
    Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:34-45.
    PubMed     Abstract available


    December 2022
  146. LAI FTT, Chan EWW, Huang L, Cheung CL, et al
    Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.
    J Am Coll Cardiol. 2022;80:2255-2265.
    PubMed     Abstract available


  147. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
    Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2224-2238.
    PubMed     Abstract available


  148. MA H, Wang X, Li X, Heianza Y, et al
    Adding Salt to Foods and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2022;80:2157-2167.
    PubMed     Abstract available


    November 2022
  149. CHANG YK, McClung JA, Allen LA, Philip J, et al
    Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach.
    J Am Coll Cardiol. 2022;80:e205-e206.
    PubMed    


  150. AREVALO LORIDO JC, Salamanca Bautista P, Formiga F, Mendez Bailon M, et al
    Tackling Palliative Care in Advanced Heart Failure.
    J Am Coll Cardiol. 2022;80:e203-e204.
    PubMed    


  151. RICKETTI DA, Krickus CL
    Strain on Palliative Care Services May Limit Resources for Advanced Heart Failure Patients.
    J Am Coll Cardiol. 2022;80:e201.
    PubMed    


  152. PAHUJA M, Johnson A, Kabir R, Bhogal S, et al
    Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2028-2049.
    PubMed     Abstract available


  153. SCHINDLER TH, Valenta I, Dilsizian V
    Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure.
    J Am Coll Cardiol. 2022;80:1897-1899.
    PubMed    


  154. BAI Y, Yun M, Nie B, Shan L, et al
    Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1884-1896.
    PubMed     Abstract available


  155. GIUSTINO G, Camaj A, Kapadia SR, Kar S, et al
    Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
    J Am Coll Cardiol. 2022;80:1857-1868.
    PubMed     Abstract available


  156. NASSIF ME, Januzzi JL Jr
    Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?
    J Am Coll Cardiol. 2022;80:1785-1787.
    PubMed    


  157. VADUGANATHAN M, Claggett BL, Jhund P, de Boer RA, et al
    Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1775-1784.
    PubMed     Abstract available


  158. AL-MOHAMMAD A
    Circulating Plant-Based Omega-3 in Heart Failure: A Prognostic Marker or a Therapeutic Target?
    J Am Coll Cardiol. 2022;80:1759-1761.
    PubMed    


  159. LAZARO I, Lupon J, Cediel G, Codina P, et al
    Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1751-1758.
    PubMed     Abstract available


  160. ZANNAD F
    Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same Coin.
    J Am Coll Cardiol. 2022;80:1732-1734.
    PubMed    


  161. SARRAJU A, Bakris G, Cannon CP, Cherney D, et al
    Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
    J Am Coll Cardiol. 2022;80:1721-1731.
    PubMed     Abstract available


    October 2022
  162. SALAH HM, Goldberg LR, Molinger J, Felker GM, et al
    Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1647-1659.
    PubMed     Abstract available


  163. MOHEBI R, Liu Y, Pina IL, Prescott MF, et al
    Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1529-1541.
    PubMed     Abstract available


  164. WALSH MN
    Guideline-Directed Medical Therapy: Even a Little Is Better Than None.
    J Am Coll Cardiol. 2022;80:1542-1544.
    PubMed    


  165. ASCHER SB, de Lemos JA, Lee M, Wu E, et al
    Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2022;80:1516-1525.
    PubMed     Abstract available


  166. JANUSZEWICZ A, Mulatero P, Dobrowolski P, Monticone S, et al
    Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:1480-1497.
    PubMed     Abstract available


  167. SAVVATIS K, Vissing CR, Klouvi L, Florian A, et al
    Cardiac Outcomes in Adults With Mitochondrial Diseases.
    J Am Coll Cardiol. 2022;80:1421-1430.
    PubMed     Abstract available


  168. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    PubMed     Abstract available


  169. D'ALESSANDRO DA, Wolfe SB, Osho AA, Drezek K, et al
    Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death.
    J Am Coll Cardiol. 2022;80:1314-1326.
    PubMed     Abstract available


    September 2022
  170. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    PubMed    


  171. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    PubMed     Abstract available


  172. KARAMLOU T, Devlin PJ, Hammoud MS
    Late Systemic Right Ventricle Failure: Moving Toward a Real-Time Prediction Tool.
    J Am Coll Cardiol. 2022;80:964-966.
    PubMed    


  173. BROBERG CS, van Dissel A, Minnier J, Aboulhosn J, et al
    Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries.
    J Am Coll Cardiol. 2022;80:951-963.
    PubMed     Abstract available


    August 2022
  174. IDRISS SF, Weiland MD
    Ventricular Pacing in Single Ventricle Circulation: Making the Best of a Difficult Situation.
    J Am Coll Cardiol. 2022;80:915-917.
    PubMed    


  175. BUTT JH, Dewan P, Jhund PS, Anand IS, et al
    Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05596.
    PubMed     Abstract available


  176. AHMAD T, Desai NR, Velazquez EJ
    SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05770.
    PubMed    


  177. CUNNINGHAM JW, Vaduganathan M, Claggett BL, Kulac IJ, et al
    Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05673.
    PubMed     Abstract available


  178. LA GERCHE A, Howden EJ, Haykowsky MJ, Lewis GD, et al
    Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome: JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)05603.
    PubMed     Abstract available


  179. LAU ES, Ho JE
    Reply: Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e61-e62.
    PubMed    


  180. MARTINEZ-SELLES M
    Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e59.
    PubMed    


  181. CORBALAN R, Acevedo M
    Glifozins and Atrial Fibrillation.
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
    PubMed    


  182. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
    Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
    J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
    PubMed     Abstract available


  183. HECKMAN GA, Rockwood K
    Frailty, Risk, and Heart Failure Care: Commission or Omission?
    J Am Coll Cardiol. 2022 Aug 12. pii: S0735-1097(22)05597.
    PubMed    


  184. BOCCHI EA, Lima IGCV
    The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
    J Am Coll Cardiol. 2022;80:595-597.
    PubMed    


  185. YE F, Wang X, Wu S, Ma S, et al
    Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    J Am Coll Cardiol. 2022;80:584-594.
    PubMed     Abstract available


  186. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed     Abstract available


  187. WILEY BM, Borlaug BA, Kane GC
    Lung Ultrasound in Heart Failure: Envisioning Handheld Ultrasound to Empower Nurses and Transform Health Care.
    J Am Coll Cardiol. 2022;80:524-526.
    PubMed    


  188. ZISIS G, Yang Y, Huynh Q, Whitmore K, et al
    Nurse-Provided Lung and Inferior Vena Cava Assessment in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:513-523.
    PubMed     Abstract available


    July 2022
  189. BADRAN S, Lee S
    Even in Heart Failure, Integrating Palliative Care and Aggressive Medical Therapy Is a Thing.
    J Am Coll Cardiol. 2022;80:345-347.
    PubMed    


  190. CHANG YK, Allen LA, McClung JA, Denvir MA, et al
    Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
    J Am Coll Cardiol. 2022;80:332-344.
    PubMed     Abstract available


  191. KOCHAR A, Smilowitz NR, Hochman JS
    Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
    J Am Coll Cardiol. 2022;80:199-201.
    PubMed    


  192. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
    Criteria for Defining Stages of Cardiogenic Shock Severity.
    J Am Coll Cardiol. 2022;80:185-198.
    PubMed     Abstract available


  193. JANUZZI JL JR, Butler J
    The Importance of Worsening Heart Failure: Hiding in Plain Sight.
    J Am Coll Cardiol. 2022;80:123-125.
    PubMed    


  194. AMBROSY AP, Parikh RV, Sung SH, Tan TC, et al
    Analysis of Worsening Heart Failure Events in an Integrated Health Care System.
    J Am Coll Cardiol. 2022;80:111-122.
    PubMed     Abstract available


  195. SAUER AJ
    Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?
    J Am Coll Cardiol. 2022;80:19-21.
    PubMed    


  196. BOHM M, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.
    J Am Coll Cardiol. 2022;80:1-18.
    PubMed     Abstract available


  197. FLORIDO R, Daya NR, Ndumele CE, Koton S, et al
    Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;80:22-32.
    PubMed     Abstract available


    June 2022
  198. WASFY JH, O'Kelly AC
    Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage.
    J Am Coll Cardiol. 2022;79:2526-2528.
    PubMed    


  199. FARIDI KF, Dayoub EJ, Ross JS, Dhruva SS, et al
    Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
    J Am Coll Cardiol. 2022;79:2516-2525.
    PubMed     Abstract available


  200. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    PubMed     Abstract available


  201. BIONDI-ZOCCAI G, Peruzzi M, Frati G
    Is Smoking Cessation the Best Intervention Ever to Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2306-2309.
    PubMed    


  202. DING N, Shah AM, Blaha MJ, Chang PP, et al
    Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;79:2298-2305.
    PubMed     Abstract available


  203. VERMA S, Pandey A, Bhatt DL
    Forecasting Heart Failure Risk in Diabetes.
    J Am Coll Cardiol. 2022;79:2294-2297.
    PubMed    


  204. ECHOUFFO-TCHEUGUI JB, Ndumele CE, Zhang S, Florido R, et al
    Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;79:2285-2293.
    PubMed     Abstract available


  205. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    PubMed     Abstract available


    May 2022
  206. SCHOCKEN DD
    Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2034-2036.
    PubMed    


  207. BUGIARDINI R, Yoon J, Mendieta G, Kedev S, et al
    Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.
    J Am Coll Cardiol. 2022;79:2021-2033.
    PubMed     Abstract available


  208. UDELL JA, Jones WS, Petrie MC, Harrington J, et al
    Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2058-2068.
    PubMed     Abstract available


  209. NORRISH G, Cleary A, Field E, Cervi E, et al
    Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1986-1997.
    PubMed     Abstract available


  210. DALY KP, Zuckerman WA
    The Burden of Pediatric Heart Failure That Lies Just Under the Surface.
    J Am Coll Cardiol. 2022;79:1929-1931.
    PubMed    


  211. AMDANI S, Marino BS, Rossano J, Lopez R, et al
    Burden of Pediatric Heart Failure in the United States.
    J Am Coll Cardiol. 2022;79:1917-1928.
    PubMed     Abstract available


  212. FUDIM M, Kaye DM, Borlaug BA, Shah SJ, et al
    Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1858-1869.
    PubMed     Abstract available


    April 2022
  213. DRIGGIN E, Cohen LP, Gallagher D, Karmally W, et al
    Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1623-1635.
    PubMed     Abstract available


  214. DEFILIPPIS EM
    Infertility: A Fertile Ground for Heart Failure?
    J Am Coll Cardiol. 2022;79:1604-1605.
    PubMed    


  215. LAU ES, Wang D, Roberts M, Taylor CN, et al
    Infertility and Risk of Heart Failure in the Women's Health Initiative.
    J Am Coll Cardiol. 2022;79:1594-1603.
    PubMed     Abstract available


  216. NEGISHI K, Pathan F
    Novel Left Atrial Markers for Risk Stratification of Heart Failure: Ready for Prime Time?
    J Am Coll Cardiol. 2022;79:1562-1564.
    PubMed    


  217. INCIARDI RM, Claggett B, Minamisawa M, Shin SH, et al
    Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
    J Am Coll Cardiol. 2022;79:1549-1561.
    PubMed     Abstract available


  218. KHAN SS, Beach LB, Yancy CW
    Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7.
    J Am Coll Cardiol. 2022;79:1530-1541.
    PubMed     Abstract available


  219. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed     Abstract available


  220. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
    Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
    J Am Coll Cardiol. 2022;79:1429-1437.
    PubMed     Abstract available


  221. LINDLEY KJ, Williams D, Davila-Roman VG
    Reply: When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e243.
    PubMed    


  222. SCIATTI E, Orabona R
    When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e241.
    PubMed    


  223. KRIEGER EV, Kim YY
    Lumping vs Splitting in Adult Congenital Heart Disease Research.
    J Am Coll Cardiol. 2022;79:1366-1368.
    PubMed    


    March 2022
  224. FERREIRA JP, Butler J, Zannad F, Filippatos G, et al
    Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:1129-1137.
    PubMed     Abstract available


  225. VAN SPALL HGC, Fonarow GC, Mamas MA
    Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(22)04564.
    PubMed    


  226. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08394.
    PubMed     Abstract available


  227. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08395.
    PubMed     Abstract available


  228. VARSHNEY AS, DeFilippis EM, Cowger JA, Netuka I, et al
    Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.
    J Am Coll Cardiol. 2022;79:1092-1107.
    PubMed     Abstract available


  229. GHAZI L, Yamamoto Y, Riello RJ, Coronel-Moreno C, et al
    Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    J Am Coll Cardiol. 2022 Mar 19. pii: S0735-1097(22)04489.
    PubMed     Abstract available


  230. PALAU P, Seller J, Dominguez E, Bayes-Genis A, et al
    Reply: Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:e197-e198.
    PubMed    


  231. FAUCHIER L, Bodin A, Bisson A
    Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:e195.
    PubMed    


  232. JANUZZI JL JR, Ohman EM
    Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.
    J Am Coll Cardiol. 2022;79:861-863.
    PubMed    


  233. ZHENG J, Heidenreich PA, Kohsaka S, Fearon WF, et al
    Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2022;79:849-860.
    PubMed     Abstract available


  234. TOPKARA VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, et al
    Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.
    J Am Coll Cardiol. 2022;79:900-913.
    PubMed     Abstract available


  235. JEFFERIES JL, Saffitz JE
    Autophagy and Reverse Remodeling: A New Biomarker in Heart Failure?
    J Am Coll Cardiol. 2022;79:802-804.
    PubMed    


  236. KANAMORI H, Yoshida A, Naruse G, Endo S, et al
    Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:789-801.
    PubMed     Abstract available


    February 2022
  237. FIUZAT M, Hamo CE, Butler J, Abraham WT, et al
    Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:504-510.
    PubMed     Abstract available


  238. VADUGANATHAN M, Sattar N, Xu J, Butler J, et al
    Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
    J Am Coll Cardiol. 2022;79:432-444.
    PubMed     Abstract available


  239. FONTES JD, Massera D
    The Path to Better Understanding Heart Failure Epidemiology.
    J Am Coll Cardiol. 2022;79:369-371.
    PubMed    


  240. CHANDRA A, Skali H, Claggett B, Solomon SD, et al
    Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.
    J Am Coll Cardiol. 2022;79:355-368.
    PubMed     Abstract available


  241. MASINI G, Graham FJ, Pellicori P, Cleland JGF, et al
    Criteria for Iron Deficiency in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;79:341-351.
    PubMed     Abstract available


  242. COSTANZO MR, Januzzi JL Jr
    21st Century CE: The New Iron Age?
    J Am Coll Cardiol. 2022;79:352-354.
    PubMed    


    January 2022
  243. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
    Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
    J Am Coll Cardiol. 2022;79:267-279.
    PubMed     Abstract available


  244. WALSH MN
    Change in Lifetime Risk of Heart Failure: Applicable to All?
    J Am Coll Cardiol. 2022;79:264-266.
    PubMed    


  245. VASAN RS, Enserro DM, Beiser AS, Xanthakis V, et al
    Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
    J Am Coll Cardiol. 2022;79:250-263.
    PubMed     Abstract available


  246. MANTOVANI A, Byrne CD, Benfari G, Bonapace S, et al
    Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:180-191.
    PubMed     Abstract available


  247. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    PubMed     Abstract available


  248. BERRY C, Ibanez B
    Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.
    J Am Coll Cardiol. 2022;79:49-51.
    PubMed    


    December 2021
  249. EMERSON D, Chikwe J, Catarino P, Kobashigawa J, et al
    Reply: Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
    J Am Coll Cardiol. 2021;78:e323.
    PubMed    


  250. RODENAS-ALESINA E, Billia F, Rao V, Ross HJ, et al
    Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
    J Am Coll Cardiol. 2021;78:e321.
    PubMed    


  251. PINA IL, Jimenez S, Lewis EF, Morris AA, et al
    Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.
    J Am Coll Cardiol. 2021;78:2589-2598.
    PubMed     Abstract available


  252. RAME JE, Pagani FD, Kiernan MS, Oliveira GH, et al
    Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.
    J Am Coll Cardiol. 2021;78:2294-2308.
    PubMed     Abstract available


  253. HONIGBERG MC
    Understanding Heart Failure in Women With Preeclampsia: A Call for Prevention.
    J Am Coll Cardiol. 2021;78:2291-2293.
    PubMed    


  254. WILLIAMS D, Stout MJ, Rosenbloom JI, Olsen MA, et al
    Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2281-2290.
    PubMed     Abstract available


    November 2021
  255. GANDHI PU, Windish DM
    Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
    J Am Coll Cardiol. 2021;78:2265-2266.
    PubMed    


  256. PALAU P, Seller J, Dominguez E, Sastre C, et al
    Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2042-2056.
    PubMed     Abstract available


  257. GUAZZI M
    The Link Between Heart Rate, Exercise, and beta-Blocker in HFpEF: Time to Untie the Knot.
    J Am Coll Cardiol. 2021;78:2057-2059.
    PubMed    


  258. ZHANG J, Bolli R, Garry DJ, Marban E, et al
    Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:2092-2105.
    PubMed     Abstract available


  259. GOTTLIEB SH
    Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
    J Am Coll Cardiol. 2021;78:2013-2016.
    PubMed    


  260. RAO VN, Murray E, Butler J, Cooper LB, et al
    In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2004-2012.
    PubMed     Abstract available


  261. KINDEL SJ
    Pediatric Data for Pediatric Heart Failure: Stepping Out on Our Own.
    J Am Coll Cardiol. 2021;78:1901-1903.
    PubMed    


  262. PALM J, Holdenrieder S, Hoffmann G, Horer J, et al
    Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.
    J Am Coll Cardiol. 2021;78:1890-1900.
    PubMed     Abstract available


  263. AMBARDEKAR AV, Stratton MS, Dobrinskikh E, Hunter KS, et al
    Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.
    J Am Coll Cardiol. 2021;78:1782-1795.
    PubMed     Abstract available


  264. WANNER PM, Wulff DU, Djurdjevic M, Korte W, et al
    Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
    J Am Coll Cardiol. 2021;78:1753-1764.
    PubMed     Abstract available


    October 2021
  265. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
    Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;78:1751-1752.
    PubMed    


  266. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
    Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1682-1699.
    PubMed     Abstract available


  267. ITOGA NK, Tawfik DS, Montez-Rath ME, Chang TI, et al
    Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
    J Am Coll Cardiol. 2021;78:1671-1678.
    PubMed     Abstract available


  268. RANGASWAMI J, Lo KB, Vaduganathan M, Mathew RO, et al
    Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.
    J Am Coll Cardiol. 2021;78:1669-1670.
    PubMed    


  269. SEGAR MW, Khan MS, Patel KV, Butler J, et al
    Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
    J Am Coll Cardiol. 2021;78:1587-1598.
    PubMed     Abstract available


  270. KENCHAIAH S, Budoff MJ, Ding J, Carr JJ, et al
    Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e113-e115.
    PubMed    


  271. BONAPACE S, Molon G, Marinelli A, Lanzoni L, et al
    Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e111.
    PubMed    


  272. LEE HH, Lee H, Cho SMJ, Kim DW, et al
    On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2021;78:1485-1495.
    PubMed     Abstract available


    September 2021
  273. BOHM M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.
    J Am Coll Cardiol. 2021;78:1337-1348.
    PubMed     Abstract available


  274. CUNNINGHAM JW, Myhre PL
    NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.
    J Am Coll Cardiol. 2021;78:1333-1336.
    PubMed    


  275. JANUZZI JL JR, Zannad F, Anker SD, Butler J, et al
    Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;78:1321-1332.
    PubMed     Abstract available


  276. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
    Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1166-1187.
    PubMed     Abstract available


    August 2021
  277. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
    Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:931-956.
    PubMed     Abstract available


  278. PAGANI FD
    Is Durable Left Ventricular Assist Device Therapy a Viable Option for the Elderly?
    J Am Coll Cardiol. 2021;78:895-897.
    PubMed    


  279. EMERSON D, Chikwe J, Catarino P, Hassanein M, et al
    Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.
    J Am Coll Cardiol. 2021;78:883-894.
    PubMed     Abstract available


  280. HERSBERGER L, Stanga Z, Schuetz P
    Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:856-857.
    PubMed    


  281. IKOMA T, Saito H, Oka T, Maekawa Y, et al
    The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:855-856.
    PubMed    


  282. DROZD M, Cubbon RM
    Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
    J Am Coll Cardiol. 2021;78:760.
    PubMed    


  283. SHEN L, Jhund PS, McMurray JJV
    Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
    J Am Coll Cardiol. 2021;78:760-761.
    PubMed    


  284. MEWTON N, Baudry G, Sebbag L
    Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
    J Am Coll Cardiol. 2021;78:759.
    PubMed    


  285. LEWANDOWSKI AJ, Raman B, Bertagnolli M, Mohamed A, et al
    Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood.
    J Am Coll Cardiol. 2021;78:683-692.
    PubMed     Abstract available


  286. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
    Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
    J Am Coll Cardiol. 2021;78:643-662.
    PubMed     Abstract available


  287. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
    Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637-638.
    PubMed    


  288. DEL BUONO MG, Van Tassell BW, Abbate A
    Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637.
    PubMed    


  289. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
    Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
    J Am Coll Cardiol. 2021;78:543-544.
    PubMed    


  290. SHCHENDRYGINA A, Mewton N, Meznar AZ
    Advanced Heart Failure and Angiotensin System Fascinating Complexities.
    J Am Coll Cardiol. 2021;78:541-542.
    PubMed    


  291. LI L, Wang J, Zhao G, Topaz S, et al
    Percutaneous DLC-Based Total Cavopulmonary Assist Achieves 96-Hour Survival in Lethal Cavopulmonary Failure Sheep.
    J Am Coll Cardiol. 2021;78:538-540.
    PubMed    


    July 2021
  292. ROSSIGNOL P, Pitt B
    Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
    J Am Coll Cardiol. 2021;78:344-347.
    PubMed    


  293. ITKIN M, Rockson SG, Burkhoff D
    Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:278-290.
    PubMed     Abstract available


  294. AMUNDSEN BH
    Atrial Strain: A Piece of the HFpEF Puzzle Found, But Not Yet in Place.
    J Am Coll Cardiol. 2021;78:258-259.
    PubMed    


  295. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.
    J Am Coll Cardiol. 2021;78:97-108.
    PubMed     Abstract available


  296. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    PubMed     Abstract available


  297. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    PubMed    


  298. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    PubMed     Abstract available


  299. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
    Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
    J Am Coll Cardiol. 2021;78:14-23.
    PubMed     Abstract available


    June 2021
  300. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    PubMed     Abstract available


  301. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    PubMed    


  302. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
    AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    J Am Coll Cardiol. 2021;77:2923-2935.
    PubMed     Abstract available


  303. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    PubMed     Abstract available


  304. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
    Pericardial Fat and the Risk of Heart Failure.
    J Am Coll Cardiol. 2021;77:2638-2652.
    PubMed     Abstract available


    May 2021
  305. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    PubMed     Abstract available


  306. GOTTLIEB SH
    Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
    J Am Coll Cardiol. 2021;77:2320-2322.
    PubMed    


  307. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
    Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
    J Am Coll Cardiol. 2021;77:2307-2319.
    PubMed     Abstract available


  308. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
    New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
    J Am Coll Cardiol. 2021;77:2260-2262.
    PubMed    


  309. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
    Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
    PubMed     Abstract available


    April 2021
  310. MANCINI D, Gibson GT
    Impact of Pneumonia in Heart Failure Patients.
    J Am Coll Cardiol. 2021;77:1974-1976.
    PubMed    


  311. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
    Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1961-1973.
    PubMed     Abstract available


  312. HONKA H, Solis-Herrera C, Triplitt C, Norton L, et al
    Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2022-2039.
    PubMed     Abstract available


  313. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
    Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1952-1953.
    PubMed    


  314. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


  315. RAUH MJ
    Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2021;77:1760-1762.
    PubMed    


  316. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
    Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1747-1759.
    PubMed     Abstract available


  317. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
    Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    J Am Coll Cardiol. 2021;77:1731-1743.
    PubMed     Abstract available


  318. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
    Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    J Am Coll Cardiol. 2021;77:1717-1727.
    PubMed     Abstract available


    March 2021
  319. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
    Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    J Am Coll Cardiol. 2021;77:1454-1469.
    PubMed     Abstract available


  320. GREENE SJ, Khan MS
    Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
    J Am Coll Cardiol. 2021;77:1408-1411.
    PubMed    


  321. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
    Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
    J Am Coll Cardiol. 2021;77:1397-1407.
    PubMed     Abstract available


  322. KOSIBOROD MN, Vaduganathan M
    SGLT-2 Inhibitors in Heart Failure: Volume or Value?
    J Am Coll Cardiol. 2021;77:1393-1396.
    PubMed    


  323. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;77:1381-1392.
    PubMed     Abstract available


  324. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
    TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
    J Am Coll Cardiol. 2021;77:1481-1483.
    PubMed    


  325. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
    SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
    J Am Coll Cardiol. 2021;77:1375-1377.
    PubMed    


  326. MCCULLOUGH PA, Rahimi G, Tecson KM
    Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1222-1224.
    PubMed    


  327. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
    Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    J Am Coll Cardiol. 2021;77:1211-1221.
    PubMed     Abstract available


  328. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
    Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:1243-1256.
    PubMed     Abstract available


  329. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    PubMed     Abstract available


  330. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
    Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2021;77:1044-1052.
    PubMed     Abstract available


    February 2021
  331. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    PubMed    


  332. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.
    PubMed    


  333. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    PubMed     Abstract available


  334. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
    Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2021;77:713-724.
    PubMed     Abstract available


  335. GOODLIN SJ
    RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
    J Am Coll Cardiol. 2021;77:504-505.
    PubMed    


  336. CHUZI S, Khan SS, Pak ES
    Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
    J Am Coll Cardiol. 2021;77:501-505.
    PubMed    


  337. FRISK M, Le C, Shen X, Roe AT, et al
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:405-419.
    PubMed     Abstract available


  338. HULOT JS, Livrozet M
    HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
    J Am Coll Cardiol. 2021;77:420-422.
    PubMed    


    January 2021
  339. GOLDBERG LR
    The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
    J Am Coll Cardiol. 2021;77:256-258.
    PubMed    


  340. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
    Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
    PubMed    


  341. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
    J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
    PubMed    


    December 2020
  342. PAGANI FD
    Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
    J Am Coll Cardiol. 2020;76:2965-2967.
    PubMed    


  343. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
    Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    J Am Coll Cardiol. 2020;76:2940-2951.
    PubMed     Abstract available


  344. ALAHMAD B, Khraishah H
    Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
    J Am Coll Cardiol. 2020;76:2875-2877.
    PubMed    


  345. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
    Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
    J Am Coll Cardiol. 2020;76:2862-2874.
    PubMed     Abstract available


  346. GUPTA DK, Crescenzi R, Aday AW
    Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2830-2833.
    PubMed    


  347. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
    Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2817-2829.
    PubMed     Abstract available


  348. JANUZZI JL JR, Ibrahim NE
    Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
    J Am Coll Cardiol. 2020;76:2752-2754.
    PubMed    


  349. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
    Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2740-2751.
    PubMed     Abstract available


  350. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
    Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:2671-2681.
    PubMed     Abstract available


  351. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
    Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:2595-2606.
    PubMed     Abstract available


    November 2020
  352. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
    2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
    PubMed    


  353. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
    Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
    J Am Coll Cardiol. 2020;76:2334-2348.
    PubMed     Abstract available


  354. FASELIS C, Fonarow GC, Ahmed A
    Reply: Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418-2420.
    PubMed    


  355. DAUW J, Mullens W
    Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418.
    PubMed    


  356. PANJRATH GS, Krepp J
    COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
    J Am Coll Cardiol. 2020;76:2349-2351.
    PubMed    


  357. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.
    PubMed    


  358. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.
    PubMed    


  359. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    PubMed     Abstract available


  360. VELAZQUEZ EJ, Reinhardt SW
    Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
    J Am Coll Cardiol. 2020;76:2086-2088.
    PubMed    


    October 2020
  361. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
    Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2040-2041.
    PubMed    


  362. FUDIM M, Soloveva A
    Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2038-2039.
    PubMed    


  363. LIU PP, Al-Khalaf M, Blet A
    Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
    J Am Coll Cardiol. 2020;76:1995-1998.
    PubMed    


  364. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1982-1994.
    PubMed     Abstract available


  365. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
    Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    J Am Coll Cardiol. 2020;76:1919-1930.
    PubMed     Abstract available


  366. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
    2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
    PubMed    


  367. KITTLESON MM
    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.
    PubMed    


  368. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
    Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1795-1807.
    PubMed     Abstract available


  369. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
    Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
    J Am Coll Cardiol. 2020;76:1717-1718.
    PubMed    


  370. MEWTON N, Sebbag L, Bochaton T
    Other Things Behind the Low Rate of Heart Failure Trial Publication.
    J Am Coll Cardiol. 2020;76:1716-1717.
    PubMed    


  371. MEHMOOD M
    Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
    J Am Coll Cardiol. 2020;76:1715-1716.
    PubMed    


    September 2020
  372. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
    Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
    J Am Coll Cardiol. 2020;76:1501-1502.
    PubMed    


  373. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
    Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:1305-1314.
    PubMed     Abstract available


  374. GOTTLIEB SS, Ahmed T
    Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
    J Am Coll Cardiol. 2020;76:1049-1050.
    PubMed    


  375. GUAZZI M, Ghio S, Adir Y
    Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1102-1111.
    PubMed     Abstract available


  376. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
    Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;76:1084-1101.
    PubMed     Abstract available


    August 2020
  377. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
    Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    J Am Coll Cardiol. 2020;76:930-941.
    PubMed     Abstract available


  378. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    PubMed     Abstract available


  379. COX ZL, Stevenson LW
    The Weight of Evidence for Diuretics and Parachutes.
    J Am Coll Cardiol. 2020;76:680-683.
    PubMed    


  380. BAYES-GENIS A, Nunez J, Lupon J
    Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
    J Am Coll Cardiol. 2020;76:515-517.
    PubMed    


  381. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
    Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
    J Am Coll Cardiol. 2020;76:503-514.
    PubMed     Abstract available


    July 2020
  382. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  383. JANUZZI JL JR, Ibrahim NE
    The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
    J Am Coll Cardiol. 2020;76:14-16.
    PubMed    


    June 2020
  384. MEHRA MR, Grazette LP
    Untimely Trial Publication: A Sin of Omission?
    J Am Coll Cardiol. 2020;75:3162-3163.
    PubMed    


  385. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
    Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    J Am Coll Cardiol. 2020;75:3033-3043.
    PubMed     Abstract available


  386. PARKER WF, Chung K, Anderson AS, Siegler M, et al
    Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
    J Am Coll Cardiol. 2020;75:2906-2916.
    PubMed     Abstract available


  387. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
    Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:2851-2862.
    PubMed     Abstract available


    May 2020
  388. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
    Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
    J Am Coll Cardiol. 2020;75:2642-2644.
    PubMed    


  389. MEINERTZ T, Munzel T
    Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
    J Am Coll Cardiol. 2020;75:2107-2109.
    PubMed    


    April 2020
  390. REDFORS B, Furer A, Selker HP, Thiele H, et al
    Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    J Am Coll Cardiol. 2020;75:1743-1754.
    PubMed     Abstract available


    March 2020
  391. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
    Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1501-1502.
    PubMed    


  392. PALAZZUOLI A, Ruocco G
    Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1500-1501.
    PubMed    


  393. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1471-1487.
    PubMed     Abstract available


  394. NIJST P, Martens P, Dauw J, Tang WHW, et al
    Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2020;75:1426-1438.
    PubMed     Abstract available


  395. KITZMAN DW, Upadhya B, Felker GM
    A Biomarker Approach to Understanding HFpEF.
    J Am Coll Cardiol. 2020;75:1296-1298.
    PubMed    


  396. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    PubMed     Abstract available


  397. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
    Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
    J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
    PubMed    


  398. SABBATINI AR, Kararigas G
    Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:1074-1082.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.